Login
Diagnostics Revolutions
- Pininvest Analysis
By highlighting well respected companies providing systems for in-vitro diagnostics, including gene sequencing machines, and related services, we focus on advanced medical equipment used in clinical applications, in laboratories and in research.
The fastest growing areas, gene analysis techniques and splicing applied to fields of human identity testing, oncology research, infectious disease research, pharmacogenomics, and inherited disease boost research and product innovation in molecular biology (identifying potential drug targets), microbiology (defining how organisms evolve), medicine (tracking genetic diseases) and plant sciences
The breath of the applications with potential breakthrough in areas as diverse as healthcare, agriculture or environmental protection has opened vast opportunities for start-up companies applying the new technologies… but major uncertainties about commercial break-through leaves the potential investor exposed to extreme risk situations
To service the diagnostics market (evaluated at $ 60 billion and expected to continue to grow by 4% during the coming 5 years), manufacturers of the advanced medical equipment are placed on a strong footing
Diagnostics Revolutions • Updated:
| Name | Ticker | Exchange | Sector | Industry | Currency | Cur.Price | Mkt.Cap | Perf. | Vol. | Risk Contrib. | MDD |
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics | AXDX | NASDAQ | Health Care | Lab Analytical Instruments | USD | 16.44 | 898 M | 27.5% | 52% | 5% | -39% |
|
|
| Agilent Technologies | A | NYSE | Health Care | Medical Laboratories & Research | USD | 83.71 | 26 B | 21.6% | 26% | 3% | -20% |
|
|
| Bio-Rad Laboratories | BIO | NYSE | Health Care | Lab Analytical Instruments | USD | 354.62 | 11 B | 43.1% | 30% | 3% | -10% |
|
|
| Bio-Techne | TECH | NASDAQ | Health Care | Diagnostics | USD | 213.02 | 8.1 B | 41.5% | 26% | 4% | -15% |
|
|
| Bruker Corporation | BRKR | NASDAQ | Health Care | Lab Analytical Instruments | USD | 48.87 | 7.5 B | 61.8% | 34% | 5% | -22% |
|
|
| Cancer Genetics | CGIX | NASDAQ | Health Care | Diagnostics | USD | 6.06 | 13 M | -63.6% | 184% | 3% | -88% |
|
|
| Danaher | DHR | NYSE | Conglomerates | Industrial Conglomerates | USD | 148.52 | 107 B | 48.6% | 22% | 3% | -9% |
|
|
| Exact Sciences | EXAS | NASDAQ | Health Care | Diagnostics | USD | 87.20 | 11 B | 27.7% | 46% | 5% | -37% |
|
|
| Genomic Health | GHDX | NASDAQ | Health Care | Diagnostics | USD | 63.44 | 2.4 B | -8.5% | 38% | 3% | -39% |
|
|
| Guardant Health | GH | NASDAQ | Health Care | Diagnostics | USD | 75.90 | 7.1 B | 90.7% | 71% | 13% | -46% |
|
|
| HTG Molecular Diagnostics | HTGM | NASDAQ | Health Care | Specialized Medical Devices | USD | 0.69 | 40 M | -77.0% | 66% | 1% | -80% |
|
|
| Illumina | ILMN | NASDAQ | Health Care | Gene Editing - Cell Therapies | USD | 324.72 | 48 B | -0.5% | 36% | 3% | -29% |
|
|
| Laboratory Corporation Of America | LH | NYSE | Health Care | Diagnostics | USD | 166.59 | 16 B | 21.2% | 21% | 2% | -10% |
|
|
| NanoString Technologies | NSTG | NASDAQ | Health Care | Diagnostics | USD | 25.53 | 912 M | 55.7% | 52% | 7% | -38% |
|
|
| NeoGenomics | NEO | NASDAQ | Health Care | Gene Editing - Cell Therapies | USD | 26.42 | 2.8 B | 99.4% | 41% | 8% | -28% |
|
|
| OPKO Health | OPK | NASDAQ | Health Care | Diagnostics | USD | 1.56 | 1.0 B | -52.6% | 64% | 2% | -63% |
|
|
| Pacific Biosciences of California | PACB | NASDAQ | Health Care | Medical Technology | USD | 5.52 | 845 M | -26.1% | 30% | 1% | -39% |
|
|
| Perkinelmer | PKI | NYSE | Health Care | Lab Analytical Instruments | USD | 94.39 | 10 B | 13.1% | 26% | 3% | -22% |
|
|
| Quest Diagnostics Inc. | DGX | NYSE | Health Care | Diagnostics | USD | 105.20 | 14 B | 25.5% | 20% | 2% | -7% |
|
|
| Quidel Corp | QDEL | NASDAQ | Health Care | Diagnostics | USD | 70.82 | 2.9 B | 41.9% | 38% | 5% | -23% |
|
|
| Sonic Healthcare | SKHHY | OTC | Health Care | Diagnostics | USD | 20.04 | - | 31.4% | 20% | 1% | -7% |
|
|
| Thermo Fisher Scientific | TMO | NYSE | Health Care | Lab Analytical Instruments | USD | 320.50 | 129 B | 37.2% | 24% | 3% | -12% |
|
|
| Veracyte | VCYT | NASDAQ | Health Care | Gene Editing - Cell Therapies | USD | 28.51 | 1.4 B | 133.3% | 56% | 12% | -33% |
|
|
| Waters Corp. | WAT | NYSE | Health Care | Lab Analytical Instruments | USD | 234.11 | 15 B | 23.9% | 28% | 2% | -21% |
|